EMUC15 - Resource Centre - Search Results


Testosterone suppression with an innovative form of leuprorelin acetate as solid biodegradable implant in patients with advanced prostate cancer. Results from four trials and comparison with traditional leuprorelin acetate microcapsules formulation

By: Solarić M.2, Bjartell A.3, Thyroff-Friesinger U.4, Meani D.1
Institutes: 1Sandoz International GmbH, , Holzkirchen, 2University Hospital Center Zagreb, Dept. of Oncology, Zagreb, 3Skåne University Hospital, Dept. of Urology, Malmö, 4Hexal AG, Holzkirchen
  • Type: Document
  • Date: 12-11-2015
  • Rating: 0,0
  • Views: 392
  • Event: 7th European Multidisciplinary Meeting on Urological Cancers
  • Nr: P071